Other languages Jiuzhitang Co., Ltd.

Equities

000989

CNE000001394

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
6.9 ^CNY	+2.07%		+3.45%	-31.82%

08/05	Jiuzhitang Co., Ltd.(XSEC:000989) dropped from S&P Global BMI Index	CI
24/04	Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jiuzhitang Co., Ltd. Approves Final Cash Dividend for the Year 2023	21/05
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend (Tax Included) for 2023	25/04
Jiuzhitang Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Jiuzhitang Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	18/03
Jiuzhitang Co., Ltd. authorizes a Buyback Plan.	18/03
Jiuzhitang's Unit to Launch Clinical Trials Into Human Bone Marrow Stem Cell Injection; Shares Drop 3%	02/11
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	08/23/08
Jiuzhitang Unit to Hold Clinical Trial Into Stem Cell Treatment	12/23/12
Jiuzhitang Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 06 June 2023	31/23/31
Jiuzhitang Co., Ltd. Approves Cash Dividend for the Year 2022	26/23/26
Jiuzhitang Co., Ltd. Proposes Final Cash Dividend for 2022	05/23/05
Jiuzhitang Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/23/28
Jiuzhitang Co., Ltd. Appoints Bo Jinfeng as Non-Independent Director	12/23/12
Jiuzhitang Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28
Jiuzhitang Cleared to Launch Clinical Trial of Deep Vein Thrombosis Drug	22/22/22
Jiuzhitang Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30
Jiuzhitang Co., Ltd. Appoints Wang Yonghui as a Non-Independent Director	18/22/18
Jiuzhitang Co., Ltd. Announces Final Cash Dividend for 2021 Payable on 01 June 2022	27/22/27
Yifeng Pharmacy Chain Co., Ltd. completed the acquisition of a 51% stake in Hunan Jiuzhitang Pharmaceutical Co., Ltd. from Jiuzhitang Co., Ltd..	26/22/26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jiuzhitang Co., Ltd.

Equities

000989

CNE000001394

Other languages

Filters